{"name":"Neutec Ar-Ge San ve Tic A.Ş","slug":"neutec-ar-ge-san-ve-tic-a","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"immunology","drugs":[{"name":"Ipratropium + Levosalbutamol Free Dose Combination","genericName":"Ipratropium + Levosalbutamol Free Dose Combination","slug":"ipratropium-levosalbutamol-free-dose-combination","indication":"Acute bronchospasm in chronic obstructive pulmonary disease (COPD)","status":"phase_3"},{"name":"Tiotropium/Formoterol","genericName":"Tiotropium/Formoterol","slug":"tiotropium-formoterol","indication":"Chronic obstructive pulmonary disease (COPD) maintenance therapy","status":"marketed"},{"name":"Acetylcysteine/Doxofylline","genericName":"Acetylcysteine/Doxofylline","slug":"acetylcysteine-doxofylline","indication":"Chronic obstructive pulmonary disease (COPD) with excessive mucus production","status":"marketed"},{"name":"Ipratropium / Levosalbutamol Fixed Dose Combination","genericName":"Ipratropium / Levosalbutamol Fixed Dose Combination","slug":"ipratropium-levosalbutamol-fixed-dose-combination","indication":"Chronic obstructive pulmonary disease (COPD)","status":"phase_3"},{"name":"Salmeterol/Fluticasone Capsair®","genericName":"Salmeterol/Fluticasone Capsair®","slug":"salmeterol-fluticasone-capsair","indication":"Asthma maintenance therapy","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Infex 400 MR","genericName":"Infex 400 MR","slug":"infex-400-mr","indication":"Community-acquired pneumonia","status":"phase_3"},{"name":"Infex 200 IR","genericName":"Infex 200 IR","slug":"infex-200-ir","indication":"Community-acquired pneumonia","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Lansoprazole/Domperidone","genericName":"Lansoprazole/Domperidone","slug":"lansoprazole-domperidone","indication":"Gastroesophageal reflux disease (GERD) with associated nausea or dysmotility","status":"marketed"}]}],"pipeline":[{"name":"Infex 400 MR","genericName":"Infex 400 MR","slug":"infex-400-mr","phase":"phase_3","mechanism":"Infex 400 MR is a macrolide antibiotic that inhibits bacterial protein synthesis.","indications":["Community-acquired pneumonia","Acute exacerbations of chronic bronchitis","Mild to moderate chronic bronchitis"],"catalyst":""},{"name":"Ipratropium + Levosalbutamol Free Dose Combination","genericName":"Ipratropium + Levosalbutamol Free Dose Combination","slug":"ipratropium-levosalbutamol-free-dose-combination","phase":"phase_3","mechanism":"This combination uses an anticholinergic bronchodilator (ipratropium) and a short-acting beta-2 agonist (levosalbutamol) to relax airway smooth muscle through complementary pathways.","indications":["Acute bronchospasm in chronic obstructive pulmonary disease (COPD)","Asthma exacerbation","Reversible airway obstruction"],"catalyst":""},{"name":"Tiotropium/Formoterol","genericName":"Tiotropium/Formoterol","slug":"tiotropium-formoterol","phase":"marketed","mechanism":"Tiotropium is a long-acting anticholinergic that blocks muscarinic receptors to relax airway smooth muscle, while formoterol is a long-acting beta-2 agonist that stimulates bronchodilation, together providing sustained airway opening for chronic obstructive pulmonary disease.","indications":["Chronic obstructive pulmonary disease (COPD) maintenance therapy","Asthma maintenance therapy"],"catalyst":""},{"name":"Acetylcysteine/Doxofylline","genericName":"Acetylcysteine/Doxofylline","slug":"acetylcysteine-doxofylline","phase":"marketed","mechanism":"Acetylcysteine acts as a mucolytic agent to break down mucus, while doxofylline is a xanthine derivative that acts as a bronchodilator and anti-inflammatory agent.","indications":["Chronic obstructive pulmonary disease (COPD) with excessive mucus production","Acute and chronic bronchitis","Asthma with mucus obstruction","Cystic fibrosis"],"catalyst":""},{"name":"Infex 200 IR","genericName":"Infex 200 IR","slug":"infex-200-ir","phase":"phase_3","mechanism":"Infex 200 IR is an antibiotic that works by inhibiting bacterial cell wall synthesis.","indications":["Community-acquired pneumonia","Nosocomial pneumonia"],"catalyst":""},{"name":"Ipratropium / Levosalbutamol Fixed Dose Combination","genericName":"Ipratropium / Levosalbutamol Fixed Dose Combination","slug":"ipratropium-levosalbutamol-fixed-dose-combination","phase":"phase_3","mechanism":"This combination drug relaxes airway muscles through dual action: ipratropium blocks acetylcholine receptors to reduce bronchoconstriction, while levosalbutamol stimulates beta-2 adrenergic receptors to promote bronchodilation.","indications":["Chronic obstructive pulmonary disease (COPD)","Asthma (acute bronchospasm relief)"],"catalyst":""},{"name":"Lansoprazole/Domperidone","genericName":"Lansoprazole/Domperidone","slug":"lansoprazole-domperidone","phase":"marketed","mechanism":"Lansoprazole reduces stomach acid by inhibiting the proton pump, while domperidone enhances gastric motility and prevents nausea by blocking dopamine receptors.","indications":["Gastroesophageal reflux disease (GERD) with associated nausea or dysmotility","Peptic ulcer disease with gastric dysmotility","Functional dyspepsia with acid reflux"],"catalyst":""},{"name":"Salmeterol/Fluticasone Capsair®","genericName":"Salmeterol/Fluticasone Capsair®","slug":"salmeterol-fluticasone-capsair","phase":"marketed","mechanism":"Salmeterol/Fluticasone is a combination inhaled bronchodilator and corticosteroid that relaxes airway smooth muscle and reduces airway inflammation.","indications":["Asthma maintenance therapy","Chronic obstructive pulmonary disease (COPD) maintenance therapy"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":8,"phaseCounts":{"phase_3":4,"marketed":4},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}